A Kaiser Permanente study finds COVID-19 patients treated quickly with Paxlovid have a 90% lower risk of hospitalization and death PASADENA, Calif., March 16, 2023 /PRNewswire/ — A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.